Development, testing, and implementation of a new procedure to assess the clinical added benefit of pharmaceuticals
ObjectivesThe reimbursement process for innovative health technologies in Hungary lacks any formalized assessment of clinical added benefit (CAB). The aim of this research is to present the development, retrospective testing, and implementation of a local assessment framework for determining the CAB...
Gespeichert in:
Veröffentlicht in: | International journal of technology assessment in health care 2022-07, Vol.38 (1), p.e58-e58, Article e58 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!